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Objectives: We investigated whether baseline scores for a self-report trait linked to central mechanisms
predict 1 year pain outcomes in the Knee Pain in the Community cohort.
METHOD: 1471 participants reported knee pain at baseline and responded to a 1-year follow-up ques-
tionnaire, of whom 204 underwent pressure pain detection thresholds (PPTs) and radiographic assess-
ment at baseline. Logistic and linear regression models estimated the relative risks (RRs) and associations
(b) between self-report traits, PPTs and pain outcomes. Discriminative performance for each predictor
was compared using receiver-operator characteristics (ROC) curves.
Results: Baseline Central Mechanisms trait scores predicted pain persistence (Relative Risk, RR ¼ 2.10,
P ¼ 0.001) and persistent pain severity (b ¼ 0.47, P < 0.001), even after adjustment for age, sex, BMI,
radiographic scores and symptom duration. Baseline joint-line PPTs also associated with pain persistence
(RR range ¼ 0.65 to 0.68, P < 0.02), but only in univariate models. Lower baseline medial joint-line PPT
was associated with persistent pain severity (b ¼ 0.29, P ¼ 0.013) in a fully adjusted model. The Central
Mechanisms trait model showed good discrimination of pain persistence cases from resolved pain cases
(Area Under the Curve, AUC ¼ 0.70). The discrimination power of other predictors (PPTs (AUC
range ¼ 0.51 to 0.59), radiographic OA (AUC ¼ 0.62), age, sex and BMI (AUC range ¼ 0.51 to 0.64),
improved signiﬁcantly (P < 0.05) when the central mechanisms trait was included in each logistic
regression model (AUC range ¼ 0.69 to 0.74).
Conclusion: A simple summary self-report Central Mechanisms trait score may indicate a contribution of
central mechanisms to poor knee pain prognosis.
© 2020 The Authors. Published by Elsevier Ltd on behalf of Osteoarthritis Research Society International.
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One quarter of individuals aged over 55 have chronic knee pain,
often due to osteoarthritis (OA)1. Knee pain might be due to
structural changes or inﬂammation linked to OAwithin the affected
knee (peripheral mechanisms). However, previous experimental
and therapeutic studies have demonstrated that knee pain is often
intensiﬁed by processing of afferent signals by the central nervous
system (central mechanisms)2e5. Identiﬁcation of underlying pain
mechanisms is important for optimal management of chronic knee
pain, and for predicting responses to existing therapies6.search Society International. This is an open access article under the CC BY license
K. Akin-Akinyosoye et al. / Osteoarthritis and Cartilage 28 (2020) 173e181174Quantitative Sensory Testing (QST) modalities such as pressure
pain detection thresholds (PPT), and imaging- (e.g., functional
magnetic resonance imaging, fMRI) provide methods for assessing
central mechanisms of knee pain2. Low PPT scores distal to the
affected joint in people with OA have been associated with central
sensitization2. However, employing PPT or brain imaging would be
resource-intensive during normal clinical encounters. Thus, there is
need for a clinically feasible screening tool that identiﬁes contri-
butions to knee pain from the central nervous system. Such a
screening tool might inform mechanism-based treatment for in-
dividuals with knee pain6. Self-report traits of anxiety7,8, depres-
sion7,8, catastrophizing7,9, neuropathic-like pain7,10, fatigue7,11,
sleep disturbance7,9, pain distribution7, and cognitive impact7 each
is associated with pain intensity and clinical and experimental
markers for central pain mechanisms in individuals reporting knee
pain. In a previous study, we demonstrated that 8 self-report items,
each measuring one of these characteristics, contribute to a single
latent ‘Central Mechanisms’ trait7. This Central Mechanisms trait
was associated with pressure pain detection thresholds (PPTs) at a
distal site in individuals with knee pain, an index of central
sensitization7.
Knee pain might either resolve or persist over time. Knee pain
persistence after therapeutic intervention is weakly predicted by
structural factors within the knee, including radiographic OA and
ultrasound effusion12. Other characteristics have also been found to
predict worse pain at follow up, particularly after surgical inter-
vention. These include high Body Mass Index (BMI)13, longer
duration of pain14, PPT, and self-report traits3,4,15. However,
possible associations of central mechanisms with knee pain prog-
nosis in non-surgical contexts have been less thoroughly
explored14. In comparison to these different demographic and
disease speciﬁc predictors, self-report measures of central mecha-
nisms might more accurately predict how knee pain might change
over time across individuals. Their measurement might help to
improve knee pain prognosis by identifying individuals who might
beneﬁt from interventions aiming to reduce central sensitisation.
We hypothesized that: (i) baseline scores for a self-report Cen-
tral Mechanisms trait predict worse pain outcomes (pain persis-
tence or persistent pain severity) at 1-year follow-up in peoplewith
knee pain more strongly than any single component characteristic,
and; (ii) the prognostic performance of the Central Mechanisms
trait is superior to predictors of unfavourable pain prognosis such
as radiographic evidence of OA pathology3,4,13e15.Methods
Study population
This study is a secondary analysis of the Nottinghamshire
community-based Knee Pain and related health In the Community
(KPIC) cohort study26.
Participants aged 40 years or older provided baseline and year 1
follow-up data within, as shown in Fig. 1.
Out of 2512 participants reporting current knee pain at baseline,
1471 responded to the Knee Pain In the Community (KPIC) survey at
1-year follow-up. A subset of participants reporting knee pain for
3 years (n¼ 219) or >3 years (n¼ 103) at baseline underwent PPT
and radiographic assessments26. According to our power analyses,
to achieve 90% power with 5% type 1 error, 203 participants were
required for logistic regression analyses between pain persistence
and two covariates in the model, assuming a multiple correlation
coefﬁcient of 0.3 between covariates26.
The KPIC study protocol (clinicaltrials.gov portal:
NCT02098070) was approved by the Nottingham Research EthicsCommittee 1 (NREC Ref: 14/EM/0015) and all participants provided
informed written consent.
Self-reported questionnaires
Presence of knee pain at baseline was determined by response
to the question: “Have you had knee pain for most days of the past
month?”16. Persistence or resolution of knee pain over the past year
was determined by response to the question: “In the past 12
months, have you had any pain in or around a knee onmost days for
at least a month?”17. Knee pain severity, reported by individuals
with pain at each time point, was determined by response to the
11- point numerical rating scale (NRS) question: “In the past month,
how intense was your ‘worst knee pain’ rated on a 0e10 scale,
where 0 is ‘no pain’ and 10 is ‘pain as bad as could be’?18 Partici-
pants reporting knee pain indicated the affected knee if unilateral,
or the worst affected knee if bilateral. Individuals reporting knee
pain at baseline, but no knee pain at follow-up, were classiﬁed as a
‘resolved pain’ group, and those reporting knee pain at follow-up
were classiﬁed as a ‘pain persistence’ group.
The KPIC survey at both baseline and follow-up included
established self-report questionnaires for neuropathic-like pain
(painDETECT modiﬁed for use in people with knee OA)18, inter-
mittent and constant OA knee pain (ICOAP)19, catastrophic thinking
(Pain Catastrophizing Scale [PCS])20, and anxiety and depression
(Hospital Anxiety and Depression Scale [HADS])21. Fatigue, cogni-
tive impact22, and pain distribution23 were each measured by sin-
gle items. Rasch transformed questionnaire scores were used when
previously validated in knee pain cases (painDETECT and
ICOAP)24,25, otherwise original published protocols for scales were
followed.
Central mechanisms trait score
The Central Mechanisms trait score was derived from 8 items
(Supplementary Table 1) representative of the individual compo-
nent self-report traits measuring anxiety, catastrophizing, cognitive
impact, depression, fatigue, neuropathic-like pain, pain distribution
and sleep7. Reverse worded items were coded so that higher scores
represented greater pain or distress. Previous work established that
these 8 items contributed signiﬁcantly to one factor, interpreted as
“central pain mechanisms”. Together these items showed good
internal consistency. Raw scores were linearly transformed to
achieve a possible score range for each item of 0e3. Pain distribu-
tion classiﬁed as “pain below thewaist additional to knee pain”was
captured using areas shaded by the participant on a body manikin7.
For each participant, a summary score for the Central Mechanisms
trait (out of 24) was derived by summating transformed scores
from each of the 8 self-report items.
Pressure pain detection threshold (PPT) and radiographic
assessment
PPT and radiographic assessment were measured as described
within the KPIC study protocol26. Intra-rater and inter-rater
agreements for PPT scores used in this study have previously
been published7, and concordance correlation coefﬁcients (CCC)
were moderate (Intra-rater CCC range ¼ 0.51 to 0.86; Inter-rater
CCC range ¼ 0.39 to 0.90). Raw PPT values were logarithmically
transformed before statistical analysis to achieve normality of the
data, and normality conﬁrmed using the ShapiroeWilk test.
In this study, established radiographic OA (KL score3), deﬁned
as “deﬁnite osteophytes and deﬁnite narrowing of joint space”
within the tibiofemoral joint27, was used for the main analysis. The
Nottingham Derived Line Atlas (NDLA) approach, which classiﬁes
Fig. 1. Kpic baseline and 1-year follow-up recruitment ﬂowchart. Survey and clinical assessment data from participants reporting knee pain on most days of the past month either
at (i) baseline or (ii) at baseline and year 1 follow up, were assessed in this study. *At baseline, 322 participants with knee pain underwent PPT and radiographic assessment (these
included (i) 219 participants with early knee pain for 3 years who were selected at random from the respondents consenting to further contact; and (ii)103 participants with
established knee pain for >3 years who were age- and gender- matched to the early knee pain group). Of these, 204 (134 participoants with early knee pain at baseline, and 70
participants with established knee pain at baseline) responded to the year-1 questionnaire.
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ment28, was used in secondary analyses. Intra- and inter-rater
agreements for classiﬁcation of radiographic OA and radiographic
scoring were substantial (Supplementary Table 2).
Data analysis
Analyses were performed using Stata, version 14.229. Between-
group comparisons used Student t test and, where appropriate,
95% conﬁdence intervals (CIs) are presented. All analyses used
complete case data because of low levels of missing data (<5%).
Central mechanisms trait at baseline as a predictor of pain outcomes
at 1 year follow-up
Presence/absence of pain persistence (pain present at baseline
and year 1) served as the primary pain outcome. In those reporting
pain persistence, persistent pain severity (residualized pain
severity change scores) served as the secondary pain outcome.
Residualized change score (RCS) adjusts the portion of change in
pain between baseline and 1 year follow-up that could have been
predicted linearly from the baseline scores30,31. RCS was derived
from the following formula: RCS ¼ (Y-MY) - b(X-MX), where
Y ¼ Pain score for individual at follow-up; MY ¼ Mean score for
knee pain group at follow-up; X ¼ Pain score for individual at
baseline; MX ¼ Mean score for knee pain group at baseline;
b ¼ Regression coefﬁcient for regressing Y onto X.
Pain outcomes were entered into regression models as the
dependent variable, with baseline scores serving as the indepen-
dent variable. Univariate logistic regression models were employed
to assess and compare relationships between baseline scores and
persistence of knee pain. To ease interpretation, we used the Stata
“oddsrisk” command to convert odds ratios to risk ratios (RR) with
associated CIs32. For participants reporting persistent knee pain,
associations between RCS for knee pain severity serving as the
dependent variable, and baseline scores serving as the independent
variable, were tested using linear regression models. Associations
for linear regression models are presented as standardizedregression coefﬁcients (b). Estimates are presented from crude
models, and from fully adjusted models which accounted for other
predictors shown here or in previous studies to be associated with
knee pain persistence (including age, sex, BMI, radiographic OA,
and symptom duration)3,4,12. Spearman (r) and eta (h) CCC for
univariate associations are also presented.
Where both knees were measured during clinical assessment
(radiographic and PPT assessment), scores from the index knee
were employed.
Prognostic characteristics of the central mechanisms trait
The performance of the latent Central Mechanisms trait and
other baseline predictors in discriminating between pain persis-
tence cases and resolved pain cases was assessed using Receiver-
operator-characteristic (ROC) curves. Univariate logistic regression
models were used to estimate and compare the area under the
receiver-operator characteristics (ROC) curve (AUC) for the self-
report Central Mechanisms trait, as well as for other predictors33.
Further ROC analyses sought to establish incremental validity by
assessing whether the Central Mechanisms trait contributed
signiﬁcantly to univariate models for other predictors of pain
persistence34. To test for incremental validity, the Central Mecha-
nisms trait score was entered sequentially into logistic regression
models for each predictor.
Results
Participant characteristics
The study population comprised KPIC participants with knee
pain at baseline who responded to 1-year follow-up (n ¼ 1471,
mean (SD) age¼ 62 (10) years, BMI¼ 28.9 (6.0) kg/m2, 60% female).
As expected because of their selection criteria, participants who
underwent radiographic and PPT assessment (n ¼ 204) were
slightly younger and reported having had knee pain for a shorter
duration, but otherwise did not signiﬁcantly differ from the total
study population (Table I).
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higher baseline Central Mechanisms trait scores were associated
with longer symptom duration (r ¼ 0.14, P < 0.0001, older age
(r ¼ 0.12, P < 0.0001), female sex (h ¼ 0.30, P < 0.001) and higher
BMI (r ¼ 0.27, P < 0.0001). In those who underwent radiographic
and PPT assessment (n¼ 204), higher baseline Central Mechanisms
trait scores were associated with lower PPT at each anatomical site
(range r ¼ 0.21 to 0.37, P < 0.05) and with radiographic OA
(h ¼ 0.37, P ¼ 0.034)(Supplementary Table 3).Prediction of knee pain persistence
Knee pain persistence at 1 year was reported by 976 (66%)
participants, of whom 133 had radiographic and PPTassessments at
baseline. Compared to participants reporting pain resolution at 1-
year follow-up (n ¼ 476), those with pain persistence (n ¼ 976)
had signiﬁcantly higher baseline self-report Central Mechanisms
trait score, longer symptom duration and higher BMI (Table II).
Associations between Central Mechanisms trait and pain persis-
tence were also demonstrated in the subgroup of participants who
underwent radiographic and PPT assessment (n ¼ 204, RR ¼ 2.14,
95%C.I. 1.49,3.08, P ¼ 0.001). In this subgroup (n ¼ 204), pain
persistence was also associated with lower baseline PPT at the
medial joint line (RR ¼ 0.65, 95%C.I. 0.47, 0.89, P ¼ 0.009) and
lateral joint line (RR ¼ 0.68, 95%C.I. 0.49, 0.93, P ¼ 0.017) of the
index knee, and with the presence of radiographic OA (RR ¼ 1.69,
95%C.I. 1.40, 1.85 P ¼ 0.001)(Table II).
Prediction of pain persistence by Central Mechanisms trait score
remained signiﬁcant after adjustment for age, sex, BMI, radio-
graphic OA, and symptom duration (RR ¼ 2.10, 95%C.I. 1.36, 3.25,
P ¼ 0.001, Table III). Self-report traits of neuropathic-like symp-
toms, catastrophizing, anxiety, depression, cognitive impact and
pain distribution also signiﬁcantly predicted knee pain persistenceTable I
Participant characteristics at baseline
Total knee pain sample (n ¼
n (%) female 876 (60%)
Age; mean ± SD years 62 ± 10
BMI; mean ± SD kg/m2 28.9 ± 6.0
Self-report scores
Central Mechanisms (possible range 0e24) 8 (5e11)
Modiﬁed painDETECT (possible range -1 e 38) 12 (9e14)
Pain Catastrophising Scale (possible range 0e52) 8 (3e19)
Anxiety-HADS (possible range 0e14) 7 (4e10)
Depression-HADS (possible range 0e14) 5 (3e8)
Cognitive Impact*(possible range 0e4) 2 (0e2)
Pain Distributiony,*n (%) 791 (54%)
Fatigue*(possible range 0e4) 2 (2e3)
Sleep*(possible range 0e4) 1 (0e2)
Pain in the past month* (possible range 0e10) 4 (2e7)
Symptom duration; years 10 (4e20)
Radiography and pressure pain detection thresholds (PPT)
Radiographic OA (KL scores3); n (%) e
Proximal tibia PPT (kPa) e
Sternum PPT (KPa) e
Medial Joint Line (KPa) e
Lateral Joint Line (KPa) e
PPT ¼ Pressure Pain Detection Thresholds.
Data are median (interquartile ranges [IQRs]) except where indicated. Geometric values
Questionnaire data are presented where complete data available for questionnaire (
intermittent-ICOAP n ¼ 1319; Anxiety-Hospital Anxiety and Depression scale [HADS] n
Modiﬁed PainDETECT Questionnaire n ¼ 1155 and Central Mechanisms trait score n ¼ 1
from individuals reporting knee pain at baseline and responding at 1 year follow-up (n¼ 1
reporting knee pain at baseline and responding at 1 year follow-up who also underwen
For persistent pain severity outcome, models including self-report traits employ data from
while models for PPT and radiographic variables employ data from individuals reportin
assessment at baseline (n ¼ 133). Rows in bold indicate signiﬁcant differences between
* Measured by single items.
y Pain Distribution measured on the body pain manikin is coded as present when indin models adjusted for demographic variables, radiographic OA and
symptom duration (range RR ¼ 1.58 to 2.17, P < 0.02, Table III).
Baseline PPTs did not signiﬁcantly predict pain persistence after
adjustment for demographic variables, radiographic OA and
symptom duration (range RR ¼ 0.78 to 0.99, P > 0.25, Table III). OA
classiﬁcation using KL score2 or using the NDLA produced similar
ﬁndings to those obtained using KL score 3 (Supplementary
Table 4).Prediction of persistent pain severity
Individuals with knee pain persistence (n ¼ 976) rated their
persistent knee pain severity in the past month at 1 year follow up
as median 6 (IQR 4 to 8, possible range 0e10). Higher baseline
Central Mechanisms trait scores were associated with higher RCSs
for increasing pain severity in people with persistent knee pain
(n ¼ 1471, b ¼ 0.47, 95%C.I. 0.42,0.53, P < 0.001, Table II). Associa-
tions between baseline Central Mechanisms trait and increasing
pain severity in people with persistent knee pain were also
demonstrated in the subgroup of participants who underwent
radiographic and PPT assessment (n ¼ 133, b ¼ 0.58, 95%C.I.
0.39,0.76, P < 0.001). In this subgroup, RCS for increasing persistent
knee pain severity also was positively associated with lower base-
line PPT at the medial joint line (b ¼ -0.27, 95%C.I. 0.46, 0.07,
P ¼ 0.009) and lateral joint line (b ¼ -0.27, 95%C.I. 0.50, 0.08,
P ¼ 0.003) of the index knee, although association with the pres-
ence of radiographic OA did not reach statistical signiﬁcance
(b ¼ 0.18, 95%C.I. 0.03, 0.36 P ¼ 0.054) (Table II).
The relationship between baseline CentralMechanisms trait and
persistent knee pain severity remained signiﬁcant in models
adjusted for age, sex, BMI, radiographic OA, and symptom duration
(b ¼ 0.46; P < 0.001, Table III). After adjustment for demographic
variables, radiographic OA and symptom duration, persistent pain
severity was also signiﬁcantly predicted by self-report traits of1471) Radiographic and PPT assessed subgroup (n ¼ 204) P
124 (61%) 0.776
61 ± 10 0.018
29.5 ± 5.8 0.148
8 (5e11) 0.539
11 (9e15) 0.698
8 (3e21) 0.454
6 (4e10) 0.279
4 (3e7) 0.087
2 (0e2) 0.429
109 (53%) 0.916
2 (2e3) 0.999
1 (0e2) 0.624
4 (2e7) 0.891
2 (1e3) <0.0001
71 (35%) e
528 (420e678) e
358 (268e450) e
508 (327e692) e
1261 (1043e1451) e
for log-transformed PPTs are given for all 204 cases.
Constant-Intermittent and Constant Osteoarthritis Pain scale [ICOAP] n ¼ 1354;
¼ 1431; Depression-HADS n ¼ 1439; Pain Catastrophizing Scale [PCS], n ¼ 1409;
300). For pain persistence outcome, models including self-report traits employ data
471), while models for PPT and radiographic variables employ data from individuals
t clinical assessment at baseline (n ¼ 204).
individuals reporting knee pain both at baseline and at 1 year follow-up (n ¼ 976),
g knee pain both at baseline and at 1 year follow-up, who also underwent clinical
total sample and clinically assessed subgroup (P < 0.05).
ividual reports knee pain plus, other pain below the waist.
Table II
Participant baseline characteristics and pain persistence or persistent pain severity
Baseline characteristics Pain persistence at year 1 Persistent pain severity
Resolved pain Pain persistence p Unadjusted RR (95% CI) p Unadjusted В (95% C.I.) p
Female; n (%) 277 (58%) 591 (61%) 0.402 1.05 (0.94, 1.17) 0.402 0.06 (0.001, 0.13) 0.048
Age; mean ± SD years 62 ± 10 62 ± 10 0.643 1.03 (0.92, 1.14) 0.643 0.01 (0.06, 0.07) 0.830
BMI; mean ± SD kg/m2 28.0 ± 5.3 29.4 (6.3) 0.0001 1.29 (1.14, 1.46) <0.001 0.18 (0.11, 0.24) <0.001
Questionnaire Scores (n ¼ 476) (n ¼ 976) (n ¼ 1471) (n ¼ 976)
Central mechanisms (possible range 0e24) 6 (4e10) 9 (5e11) <0.0001 1.73 (1.52, 1.98) <0.001 0.47 (0.42, 0.53) <0.001
Modiﬁed painDETECT (possible range -1 e 38) 4 (2e9) 10 (5e16) <0.0001 2.32 (1.98, 2.72) <0.001 0.35 (0.28, 0.42) <0.001
Pain Catastrophizing Scale (possible range 0e52) 5 (2e13) 10 (4e22) <0.0001 1.65 (1.44, 1.89) <0.001 0.47 (0.41, 0.52) <0.001
Anxiety-HADS (possible range 0e14) 6 (3e9) 7 (4e11) <0.0001 1.30 (1.16, 1.46) <0.001 0.26 (0.19, 0.32) <0.001
Depression-HADS (possible range 0e14) 4 (2e7) 5 (3e8) <0.0001 1.47 (1.30, 1.66) <0.001 0.29 (0.24, 0.36) <0.001
Cognitive Impact* (possible range 0e4) 1 (0e2) 2 (1e2) <0.001 1.45 (1.29, 1.63) <0.001 0.36 (0.30, 0.42) <0.001
Pain Distribution‡,*n (%) 0 (0e1) 1 (0e1) <0.001 1.26 (1.13, 1.40) <0.001 0.12 (0.05, 0.18) <0.001
Fatigue*(possible range 0e4) 2 (2e3) 2(2e3) <0.001 1.27 (1.13, 1.42) <0.001 0.22 (0.16, 0.29) <0.001
Sleep*(possible range 0e4) 0 (0e1) 1 (0e2) <0.001 1.90 (1.66, 2.19) <0.001 0.56 (0.51, 0.61) <0.001
Symptom duration*,y; years (possible range 0e79) 7 (2e17) 11 (5e22) 0.013 1.17 (1.03, 1.32) 0.013 0.06 (0.01, 0.13) 0.102
PPT and radiographic OA (n ¼ 85) (n ¼ 118) (n ¼ 204) (n ¼ 133)
Proximal tibia PPT (kPa) 561 (518e609) 513 (473e555) 0.123 0.79 (0.58, 1.07) 0.125 0.18 (0.39, 0.02) 0.083
Sternum PPT (KPa) 365 (337e399) 337 (308e369) 0.214 0.82 (0.61, 1.12) 0.214 0.16 (0.37, 0.04) 0.110
Medial Joint Line (KPa) 523 (469e589) 407 (358e469) 0.008 0.65 (0.47, 0.89) 0.009 ¡0.27 (-0.46, -0.07) 0.008
Lateral Joint Line (KPa) 1299 (1236e1380) 1188 (1130e1249) 0.015 0.68 (0.49, 0.93) 0.017 ¡0.27 (-0.50, -0.08) 0.007
Radiographic OA (KL scores3); n (%) 6 (14%) 37 (86%) <0.001 1.69 (1.40, 1.85) 0.001 0.18 (0.03, 0.36) 0.054
Rows in bold indicate signiﬁcant associations (P < 0.05).
Baseline characteristics data are median (interquartile ranges [IQRs]) except where indicated, and standardised coefﬁcients for Risk Ratio (RR) and beta (b) are reported.
Geometric values of pressure pain detection thresholds (PPTs) are presented.
Questionnaire data are presented where complete data available for questionnaire (Constant-Intermittent and Constant Osteoarthritis Pain scale [ICOAP] n ¼ 1354;
intermittent-ICOAP n ¼ 1319; Anxiety-Hospital Anxiety and Depression scale [HADS] n ¼ 1431; Depression-HADS n ¼ 1439; Pain Catastrophizing Scale [PCS], n ¼ 1409;
Modiﬁed PainDETECT Questionnaire n ¼ 1155 and Central Mechanisms trait score n ¼ 1300).
For pain persistence outcome, models including self-report traits employ data from individuals reporting knee pain at baseline and responding at 1 year follow-up (n¼ 1471),
while models for PPT and radiographic variables employ data from individuals reporting knee pain at baseline and responding at 1 year follow-up who also underwent clinical
assessment at baseline (n ¼ 204).
For persistent pain severity outcome, models including self-report traits employ data from individuals reporting knee pain both at baseline and at 1 year follow-up (n ¼ 976),
while models for PPT and radiographic variables employ data from individuals reporting knee pain both at baseline and at 1 year follow-up, who also underwent clinical
assessment at baseline (n ¼ 133).
* Measured by single items.
y Risk ratio for pain persistence per annual increase in symptom duration.
z Pain Distribution measured on the body pain manikin was coded as present when individual reported knee pain plus other pain below the waist.
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b ¼ 0.23 to 0.63, P < 0.035), and by medial joint line PPTs
(b ¼ 0.29, P ¼ 0.013)(Table III). OA classiﬁcation using KL score2
or using the NDLA produced similar ﬁndings to those obtained
using KL score3 (Supplementary Table 4).Prognostic characteristics of the central mechanisms trait
ROC curves demonstrated good performance of baseline scores
for the Central Mechanisms trait in distinguishing pain persistence
cases from resolved pain cases in an unadjusted logistic regression
model (AUC ¼ 0.70; 95%C.I. ¼ 0.60,0.77; n ¼ 1471). The perfor-
mance of the Central Mechanisms trait model was further
improved when it was adjusted for age, sex, BMI, symptoms
duration, and radiographic OA (AUC ¼ 0.77; 95%C.I. ¼ 0.71,0.85;
n ¼ 204, P ¼ 0.007)(Fig. 2).
The performance of other predictors, including age, sex, BMI,
PPTs and radiographic OA, in distinguishing pain persistence cases
from resolved pain cases, was each improved signiﬁcantly
(P < 0.05) when the Central Mechanisms trait was included in each
logistic regression model (AUC range ¼ 0.69 to 0.74, Table IV).Discussion
In this cohort of 1471 individuals with knee pain at baseline, 66%
reported knee pain persistence at 1-year follow-up. Knee pain
persistence and persistent knee pain severity were predicted by the
self-report Central Mechanisms trait, derived from 8 componentcharacteristics (anxiety, depression, catastrophizing, neuropathic-
like pain, fatigue, sleep disturbance, pain distribution, and cogni-
tive impact). The prognostic performance of the Central Mecha-
nisms trait was superior to that of other demographic and clinical
factors, including measures of any of the 8 component character-
istics or radiographic evidence of OA pathology.
We have previously shown in a cross-sectional analysis of KPIC
participants with knee pain that the 8 self-report items used here
together deﬁned a single latent trait, and were signiﬁcantly asso-
ciated with QST evidence of central sensitisation (reduced PPT at
anatomical sites away from the affected joint)1. Previous inter-
ventional studies have also found that pain outcomes can be pre-
dicted by self-report measures of psychological distress15,35, and
experimental QST indices of central pain mechanisms3,4. Our
ﬁndings indicate that pain outcome prediction by these charac-
teristics might be explained, at least in part, by a shared Central
Mechanisms trait. Additional characteristics of cognitive impact,
catastrophizing, sleep disturbance, fatigue, neuropathic-like pain
quality and pain distribution each might contribute to this pre-
dictive trait. A composite score from self-report items, each
addressing one of these 8 characteristics, better predicted pain
outcomes than did measures of any single characteristic alone.
Our composite measure of the Central Mechanisms trait pre-
dicted cases in whom pain persisted or resolved with an AUC of
0.70. This indicates acceptable discrimination36, but also suggests
that other factors might contribute to pain outcomes. Combining
mechanistically discrete factors might further improve pain
outcome prediction, as previously found by combining
Table III
Prediction of pain persistence and persistent pain severity at year 1 follow up by baseline self-report traits and PPT in adjusted models*
Pain persistence at year 1 Persistent pain severity
RR (95% CI) P b (95% CI) p
Traits (n ¼ 1471) (n ¼ 976)
Central Mechanism 2.10 (1.36, 3.25) 0.001 0.46 (0.25, 0.68) <0.001
Neuropathic-like symptoms 2.17 (1.34, 3.49) 0.001 0.23 (0.01, 0.47) 0.057
Catastrophizing 1.94 (1.29, 2.93) 0.001 0.49 (0.32, 0.65) <0.001
Anxiety 1.61 (1.01, 2.32) 0.011 0.39 (0.20, 0.58) <0.001
Depression 1.92 (1.22, 3.02) 0.005 0.23 (0.02, 0.44) 0.035
Cognitive Impacty 1.60 (1.08, 2.37) 0.018 0.39 (0.17, 0.62) 0.001
Pain Distributiony,z 1.58 (1.14, 2.19) 0.006 0.03 (0.20, 0.21) 0.964
Fatiguey 1.36 (0.97, 1.92) 0.075 0.11 (0.11, 0.33) 0.337
Sleepy 1.98 (1.329, 3.05) 0.002 0.63 (0.46, 0.80) <0.001
PPT Scores (n ¼ 204) (n ¼ 133)
Proximal tibia PPT (kPa) 0.98 (0.67, 1.43) 0.918 0.05 (0.28, 0.17) 0.647
Sternum PPT (KPa) 0.99 (0.67, 1.46) 0.954 0.07 (0.29, 0.14) 0.493
Medial Joint Line (KPa) 0.78 (0.51, 1.19) 0.257 ¡0.29 (-0.52, -0.06) 0.013
Lateral Joint Line (KPa) 0.79 (0.54, 1.18) 0.263 0.21 (0.45, 0.02) 0.067
Rows in bold indicate signiﬁcant associations (P < 0.05).
Standardised coefﬁcients for Risk Ratio (RR) and beta (b) reported.
Variables employ data from individuals reporting knee pain at baseline and responding at 1 year follow-up who also underwent clinical assessment at baseline (n ¼ 204).
For pain persistence outcome, models including self-report traits employ data from individuals reporting knee pain at baseline and responding at 1 year follow-up (n¼ 1471),
while models for PPT and radiographic.
For persistent pain severity outcome, models including self-report traits employ data from individuals reporting knee pain both at baseline and at 1 year follow-up (n ¼ 976),
while models for PPT and radiographic variables employ data from individuals reporting knee pain both at baseline and at 1 year follow-up, who also underwent clinical
assessment at baseline (n ¼ 133).
* Each model in this table displays the relationship between each outcome (presented per column) and each exposure (presented per row), after adjusting for demographic
variables (age, sex and BMI), radiographic OA (KL scores3) and symptom duration.
y Measured by single items.
z Pain Distribution measured on the body pain manikin was coded as present when individual reported knee pain plus other pain below the waist.
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present within the tibiofemoral (AUC ¼ 0.62) or patellofemoral
(AUC ¼ 0.53) compartments signiﬁcantly predicted knee pain
persistence, and combining radiographic OA classiﬁcation with
scores for the Central Mechanism trait improved this prediction.
Indeed, scores for the Central Mechanisms trait better predicted
pain outcomes than did radiographic OA classiﬁcation. Our ﬁndings
extend previous evidence that central mechanisms might
inﬂuence pain intensity over and above effects of radiographic joint
damage 38 or disease duration37.
We found that of the sites investigated by PPT in the current
study, only joint line PPT signiﬁcantly predicted knee pain persis-
tence or severity. Furthermore, PPT predicted pain persistence less
strongly (medial joint line PPT AUC ¼ 0.59) than did the CentralFig. 2. Receiver operating characteristic (roc) curve for prediction of pain persistence by cen
(AUC) for crude (unadjusted) model, and for a model adjusted for study covariates (age, sex,
individuals who underwent radiographic and QST assessment at baseline (n¼204).Mechanisms trait, and prediction of pain persistence by PPT was
not statistically signiﬁcant after adjustment for demographic vari-
ables, radiographic OA and symptom duration. Baseline joint line
PPTs might also not predict post-arthroplasty pain40, although
another study found that PPT both at sites local to, and remote from
the affected knee predicted pain severity39. Joint line PPTs may be
inﬂuenced both by peripheral and by central sensitisation, whereas
PPT at sites away from the affected joint is more likely to reﬂect
central than peripheral sensitisation5. That peripheral sensitisation
may contribute to poor pain prognosis is also suggested by pain
prediction by radiographic OA classiﬁcation, and by ultrasound
evidence of synovitis41. Future studies should explore whether
treatments to reduce peripheral sensitisation (e.g., by inhibiting
inﬂammation or blocking nerve growth factor) can reduce kneetral mechanisms trait scores in unadjusted and adjusted models. Area Under the Curve
BMI, radiographic KL 3 and symptom duration) presented. Analyses performed across
Table IV
Central Mechanisms trait score improves performance of clinical predictors for pain persistence at 1 year-follow up
Predictors AUC (95% CI)
Predictor only AUC (95% CI) Predictor þ Central Mechanisms trait score AUC (95% CI) P value
Age 0.53 (0.44, 0.62) 0.71 (0.63, 0.79) 0.001
Sex 0.51 (0.44, 0.59) 0.70 (0.61; 0.77) 0.001
BMI 0.64 (0.56, 0.72) 0.72 (0.64, 0.80) 0.038
Symptom duration 0.62 (0.54, 0.71) 0.70 (0.62, 0.78) 0.108
Radiographic OA 0.62 (0.57, 0.68) 0.73 (0.65, 0.80) 0.001
Proximal Tibia PPT 0.55 (0.44, 0.66) 0.70 (0.59, 0.79) 0.025
Sternum PPT 0.51 (0.40, 0.62) 0.62 (0.58, 0.79) 0.014
Medial Joint Line PPT 0.58 (0.48, 0.69) 0.70 (0.59, 0.79) 0.046
Lateral Joint Line PPT 0.54 (0.43, 0.65) 0.69 (0.59, 0.79) 0.022
AUC e Area Under the Curve.
Analyses performed across individuals who underwent radiographic and QST assessment at baseline (n ¼ 204). Rows in bold indicate signiﬁcant improvement in model
following inclusion of Central Mechanisms trait (P < 0.05).
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pain outcomes by the Central Mechanisms trait in the current study
remained signiﬁcant after adjustment for PPT scores, suggesting
that central mechanisms additional to those indicated by PPT
contribute to pain outcomes. Such mechanisms might include
dysregulated descending pain modulation43.
This study has several limitations. We employed only one QST
modality (PPT) and dynamic modalities such as temporal summa-
tion37, might have greater potential to predict knee pain outcomes.
PPT assessments displayed limited reliability44,45 and wide CIs,
suggesting uncertainty of the PPT point estimates7. PPT may be
inﬂuenced by factors other than central sensitisation, such as
participant reporting styles, attention, participanteresearcher in-
teractions, and also peripheral sensitisation. Further work is
needed to conﬁrm the nature of the relationship between reliable
estimates of sensitization and the Central Mechanisms trait dis-
cussed in this study. However, we show that self-report items have
potential to identify in clinical practice people whose pain is
augmented by central mechanisms, where special skills or equip-
ment required for reliable estimation of sensitization might not be
available.
Our ﬁndings help achieve the aim of the KPIC project to identify
knee pain phenotypes and risk factors for knee pain progression26.
However, only a subpopulation of the KPIC cohort underwent
radiography and PPT. Participant selection was weighted towards
an early knee pain sample (younger and shorter symptom dura-
tion), although other measured characteristics did not differ
signiﬁcantly from the overall study population. We adjusted all
models for age and symptom duration, but it remains possible that
pain prognosis would be predicted differently in later stages of
knee pain and OA. Our measure of Central Mechanisms trait re-
quires validation in an external study population, and across
different clinical and community settings.We used several different
radiographic classiﬁcation thresholds, including the NDLA which
addresses patellofemoral changes. However, other radiographic or
imaging criteria might better predict knee pain outcomes. Our
Central Mechanisms trait score was derived as a summary score
across 8 items embedded within validated questionnaires admin-
istered as a questionnaire booklet7. Future work should determine
whether these 8 items alone, when standardised within a simple
composite tool, will also predict pain outcomes, either in cohort
studies or in response to treatment. Future work should also
determine whether other factors not investigated in this study,
such as socioeconomic factors, can predict worse pain outcomes in
people with knee pain, over and beyond the performance of the
Central Mechanisms trait.
In conclusion, we show that a single overall Central Mechanisms
trait represented by items addressing 8 individual phenotypic
traits, predicts pain persistence and persistent pain severity inpeople with knee pain. Future research should determine whether
a central mechanisms questionnaire can predict treatment re-
sponses in people with knee pain, and in other chronic pain con-
ditions where central mechanisms are at play46. Such a
questionnaire might help identify those destined to experience a
poor pain prognosis in the absence of speciﬁc intervention, and
might indicate central mechanisms that could beneﬁt from non-
pharmacological (e.g., cognitive behavioural therapy) or centrally
acting pharmacological treatment.
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